243 related articles for article (PubMed ID: 36915062)
1. Magnesium hydroxide versus macrogol/electrolytes in the prevention of opioid-induced constipation in incurable cancer patients: study protocol for an open-label, randomized controlled trial (the OMAMA study).
Kistemaker KRJ; de Graeff A; Crul M; de Klerk G; van de Ven PM; van der Meulen MP; van Zuylen L; Steegers MAH
BMC Palliat Care; 2023 Mar; 22(1):22. PubMed ID: 36915062
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
Kistemaker KRJ; Sijani F; Brinkman DJ; de Graeff A; Burchell GL; Steegers MAH; van Zuylen L
Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
[TBL] [Abstract][Full Text] [Related]
3. Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation.
Poelaert J; Koopmans-Klein G; Dioh A; Louis F; Gorissen M; Logé D; Van Op den Bosch J; van Megen YJ
Clin Ther; 2015 Apr; 37(4):784-92. PubMed ID: 25757607
[TBL] [Abstract][Full Text] [Related]
4. Opioid-induced constipation, use of laxatives, and health-related quality of life.
Christensen HN; Olsson U; From J; Breivik H
Scand J Pain; 2016 Apr; 11():104-110. PubMed ID: 28850447
[TBL] [Abstract][Full Text] [Related]
5. Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives.
Koopmans G; Simpson K; De Andrés J; Lux EA; Wagemans M; Van Megen Y
Curr Med Res Opin; 2014 Nov; 30(11):2389-96. PubMed ID: 25265132
[TBL] [Abstract][Full Text] [Related]
6. Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study.
Ozaki A; Kessoku T; Iwaki M; Kobayashi T; Yoshihara T; Kato T; Honda Y; Ogawa Y; Imajo K; Higurashi T; Yoneda M; Taguri M; Yamanaka T; Ishiki H; Kobayashi N; Saito S; Ichikawa Y; Nakajima A
Trials; 2020 Jun; 21(1):453. PubMed ID: 32487150
[TBL] [Abstract][Full Text] [Related]
7. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.
De Giorgio R; Zucco FM; Chiarioni G; Mercadante S; Corazziari ES; Caraceni A; Odetti P; Giusti R; Marinangeli F; Pinto C
Adv Ther; 2021 Jul; 38(7):3589-3621. PubMed ID: 34086265
[TBL] [Abstract][Full Text] [Related]
8. Opioid-induced constipation: a stepwise treatment algorithm feasibility study.
Davies AN; Leach C; Butler C; Patel SD; Shorthose K; Batsari K
BMJ Support Palliat Care; 2023 Dec; 13(e2):e446-e453. PubMed ID: 34348942
[TBL] [Abstract][Full Text] [Related]
9. Optimal treatment of opioid induced constipation in daily clinical practice - an observational study.
Neefjes ECW; van der Wijngaart H; van der Vorst MJDL; Ten Oever D; van der Vliet HJ; Beeker A; Rhodius CA; van den Berg HP; Berkhof J; Verheul HMW
BMC Palliat Care; 2019 Mar; 18(1):31. PubMed ID: 30922276
[TBL] [Abstract][Full Text] [Related]
10. Laxatives or methylnaltrexone for the management of constipation in palliative care patients.
Candy B; Jones L; Goodman ML; Drake R; Tookman A
Cochrane Database Syst Rev; 2011 Jan; (1):CD003448. PubMed ID: 21249653
[TBL] [Abstract][Full Text] [Related]
11. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K
Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572
[TBL] [Abstract][Full Text] [Related]
12. Constipation--modern laxative therapy.
Klaschik E; Nauck F; Ostgathe C
Support Care Cancer; 2003 Nov; 11(11):679-85. PubMed ID: 14505158
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysis.
Kanbayashi Y; Ishizuka Y; Shimizu M; Sawa S; Yabe K; Uchida M
Support Care Cancer; 2022 Jul; 30(7):5831-5836. PubMed ID: 35355120
[TBL] [Abstract][Full Text] [Related]
14. Opioid-induced constipation in patients with cancer: a "real-world," multicentre, observational study of diagnostic criteria and clinical features.
Davies A; Leach C; Butler C; Gregory A; Henshaw S; Minton O; Shorthose K; Batsari KM
Pain; 2021 Jan; 162(1):309-318. PubMed ID: 32701649
[TBL] [Abstract][Full Text] [Related]
15. Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility.
Lawson R; King F; Marsh K; Altincatal A; Cimen A
Adv Ther; 2016 Aug; 33(8):1331-46. PubMed ID: 27342744
[TBL] [Abstract][Full Text] [Related]
16. Laxatives for the management of constipation in people receiving palliative care.
Candy B; Jones L; Larkin PJ; Vickerstaff V; Tookman A; Stone P
Cochrane Database Syst Rev; 2015 May; 2015(5):CD003448. PubMed ID: 25967924
[TBL] [Abstract][Full Text] [Related]
17. Opioid-induced constipation in mixed chronic pain patients: Prevalence and predictors analysis.
Samolsky Dekel BG; Sorella MC; Vasarri A; Gori A; Melotti RM
J Opioid Manag; 2019; 15(5):375-387. PubMed ID: 31849029
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation.
Lemaire A; Pointreau Y; Narciso B; Piloquet FX; Braniste V; Sabaté JM
Support Care Cancer; 2021 Dec; 29(12):7577-7586. PubMed ID: 34120247
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety, and acceptability of polyethylene glycol 3350 without electrolytes vs magnesium hydroxide in functional constipation in children from six months to eighteen years of age: A controlled clinical trial.
Worona-Dibner L; Vázquez-Frias R; Valdez-Chávez L; Verdiguel-Oyola M
Rev Gastroenterol Mex (Engl Ed); 2023; 88(2):107-117. PubMed ID: 34961695
[TBL] [Abstract][Full Text] [Related]
20. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
Gordon M; Naidoo K; Akobeng AK; Thomas AG
Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
